GRI Bio, Inc. (GRI) IPO - S-1 Filing, Stock & Insider Activity
GRI Bio, Inc. IPO - Status & S-1 Filing
- Ticker: GRI
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2025-12-08
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- SEC CIK: 0001824293 · View the S-1 on SEC EDGAR →
GRI Bio, Inc. is pre-IPO, so no insider Form 4 transactions have been filed yet. Once insiders begin reporting trades after the offering, they will appear on this page automatically.
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
GRI Bio, Inc. (GRI) - no SEC Form 4 insider filings recorded in the last 90 days. 2 Form 8-K material event filings were reported by GRI in the last 90 days. InsiderAlpha tracks every GRI SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About GRI Bio, Inc. (GRI)
GRI Bio, Inc. trades under the ticker GRI. InsiderAlpha tracks 18 primary SEC Form 4 filings from 7 reporting insiders for GRI since 2025, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0001824293 |
90-Day SEC Filing Activity
| Form 8-K filings (90d) | 2 |
|---|---|
| Latest Form 4 filing | 2025-09-18 |
Recent GRI Form 8-K Material Events
Recent Insider Filings
- - Roelof Rongen (Director)
- - Camilla V. Simpson (Director)
- - David Leslie Szekeres (Director)
- - Leanne Kelly (Chief Financial Officer)
- - David Charles Baker (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in GRI insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
GRI Insider Trading - FAQ
- What is the latest insider trade for GRI?
- GRI Bio, Inc. (GRI) had 0 insider filings in the last 90 days, with the most recent on 2025-09-18. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying GRI stock?
- 0 insider purchases of GRI were filed in the last 90 days.
- How many insiders are selling GRI stock?
- 0 insider sales of GRI were filed in the last 90 days.
- Where can I see GRI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks GRI Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $GRML Greenland Mines Ltd
- $GTBP GT Biopharma, Inc.
- $HYEX HEALTHY EXTRACTS INC.
- $ICU SeaStar Medical Holding Corp
- $IMA ImageneBio, Inc.
- $IVF INVO Fertility, Inc.
- $JAGX Jaguar Health, Inc.
- $JBIO Jade Biosciences, Inc.
- $JUNS JUPITER NEUROSCIENCES, INC.
- $KMTS KESTRA MEDICAL TECHNOLOGIES, LTD.
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live GRI dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.